All Q4 FY26 results →
C(

Colgate-Palmolive (India) Ltd

Q4 FY26Personal Products

Colgate-Palmolive (India) Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,889
Market cap₹55.5K Cr
P/E40.5
Updated23 Aug 2026
Read4 min read

The short version

The company aims for fast top-line growth with a balanced mix of volume and pricing increases (M.S. The company is focused on fast top-line growth, prioritizing a balanced mix of volume and pricing to drive expansion (Page 21).

From Colgate-Palmolive (India) Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company aims for fast top-line growth with a balanced mix of volume and pricing increases (M.S. Jacob, p.21).
  • Mid-single-digit volume growth is considered a fair growth outlook for the next few years (Latika Chopra, p.20).
  • Volume growth will be balanced with pricing rather than relying heavily on either (M.S. Jacob, p.17).
  • Premiumization, driven by higher contribution from premium products and sub-brands, is a critical growth pillar (Prabha Narasimhan, p.18).
  • E-commerce and quick commerce channels, currently about 10% of business, are margin and market-share accretive and expected to grow faster (Prabha Narasimhan, p.21).

2 more points from Colgate-Palmolive (India) Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Colgate-Palmolive (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The transcript does not explicitly mention any current or future capex, capital investment, or strategic investment plans. However, the following related points can be inferred: - Significant investments have been stepped up behind premiumization and brand advertising, especially for premium sub-brands like Total and Visible White. - There is an ongoing emphasis on leveraging technology and AI to improve efficiency, reduce time to market, and enhance product innovation. - Automation initiatives and local sourcing are used to find cost efficiencies, with savings reinvested into product superiority. - The company is continuously building capability and investing in people and culture as strategic assets.

2 more points from Colgate-Palmolive (India) Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Personal Products

Ranked on what management guided this quarter

Guidance-ranked
1Anondita Medi.
Rev 1Mar 1
Rev 2Mar 2
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Colgate-Palmolive (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from Colgate-Palmolive (India) Limited's Analyst Meet on May 22, 2026, does not mention any details regarding the current or expected order book or pending orders. The discussion primarily focuses on: - Growth strategies emphasizing volume and pricing balance. - Premiumization and e-commerce channel growth. - Financial performance, margins, and advertising spend. - Innovations and product superiority.

2 more points from Colgate-Palmolive (India) Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Colgate-Palmolive (India) Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.6K Cr, net profit ₹353 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Personal Products this season

  • Anondita Medicare Ltd (Q4 FY26)

    Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…

  • Cupid Ltd (Q4 FY26)

    Q4 FY26 Revenue from operations: ₹119.96 Cr, up 112.39% YoY from ₹56.48 Cr in Q4 FY25 (Page 18). Key concall takeaways from Cupid Ltd's Q4 FY26 earnings call…

  • Honasa Consumer Ltd (Q4 FY26)

    Increasing contribution from focus categories, which grew 35% year-on-year and now receive over 90% of investments. Key concall takeaways from Honasa Consumer…

  • Bajaj Consumer (Q4 FY26)

    Revenue growth momentum is strong, with a 21% increase for the full year FY26 and a 30% top-line growth noted in Q4. Key concall takeaways from Bajaj Consumer…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Colgate-Palmolive (India) Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Colgate-Palmolive (India) Ltd Q4 FY26 results?

The company aims for fast top-line growth with a balanced mix of volume and pricing increases (M.S. The company is focused on fast top-line growth, prioritizing a balanced mix of volume and pricing to drive expansion (Page 21).

What is Colgate-Palmolive (India) Ltd share price analysis?

Colgate-Palmolive (India) Ltd currently shows a neutral. The stock trades at a P/E of 40.5 with a market cap of ₹55,485 Cr. Investors should review the full earnings analysis for detailed insights.

Is Colgate-Palmolive (India) Ltd planning capital expenditure?

The transcript does not explicitly mention any current or future capex, capital investment, or strategic investment plans.

Keep Colgate-Palmolive (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.